Trademark: 79331299
Word
UROVANT SCIENCES
Status
Registered
Status Code
700
Status Date
Tuesday, January 3, 2023
Serial Number
79331299
Registration Number
6938285
Registration Date
Tuesday, January 3, 2023
Mark Type
5000
Filing Date
Tuesday, October 26, 2021
Published for Opposition
Tuesday, October 18, 2022

Trademark Owner History
Urovant Sciences GmbH - Original Registrant

Classifications
41 Providing educational information in the academic fields relating to prevention, identification and treatment of diseases related to medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the academic fields of biological and pharmaceutical preparations for the prevention of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the fields of prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for medical purposes; educational and entertainment services, namely, providing motivational and educational speakers in the fields of medicine, health, pharmaceuticals, and disease and disorder identification, treatment and prevention; providing online non-downloadable articles in the fields of medicine, health, pharmaceuticals and disease and disorder identification, treatment and prevention
5 Pharmaceutical and biological preparations, for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; pharmaceutical preparations for human use for the treatment of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the treatment of medical conditions, namely, urological, urinary tract system and reproductive organ disorders
38 Providing online chat rooms for transmission of messages among computer users concerning disease prevention, identification and treatment education relating to medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; peer-to-peer network computer services, namely, electronic transmission of audio sequences, video sequences as well as other data and documents among computers, such audio sequences, video sequences and other data and documents all relating to prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; providing online chat rooms for transmission of messages among computer users concerning the fields of biological and pharmaceutical preparations; peer-to-peer network computer services, namely, electronic transmission of audio sequences, video sequences as well as other data and documents among computers, such audio sequences, video sequences and other data and documents all relating to the fields of biological and pharmaceutical preparations
44 Provision of health information and medical information, all for treatment and diagnostic purposes; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, conditions, disorders and pathologies; providing health care advice and medical advice in the fields of prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical use
The mark consists of the word "UROVANT". The letter "A" contains a wavy line design. Below the "VANT" is the word "SCIENCES" in a smaller font.
"SCIENCES"

Trademark Events
Apr 8, 2024
Teas Change Of Correspondence Received
Apr 8, 2024
Teas Withdrawal As Domestic Representative Received
Apr 8, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 8, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 8, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 8, 2024
Teas Change Of Owner Address Received
Feb 23, 2024
New Representative At Ib Received
May 17, 2023
Final Decision Transaction Processed By Ib
Apr 20, 2023
Final Disposition Notice Sent To Ib
Apr 20, 2023
Final Disposition Processed
Apr 3, 2023
Final Disposition Notice Created, To Be Sent To Ib
Mar 18, 2023
Change Of Name/Address Rec'd From Ib
Jan 3, 2023
Notice Of Registration Confirmation Emailed
Jan 3, 2023
Registered-Principal Register
Nov 25, 2022
New Representative At Ib Received
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 12, 2022
Approved For Pub - Principal Register
Sep 1, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Correspondence Received In Law Office
Aug 31, 2022
Teas Response To Office Action Received
Apr 30, 2022
New Representative At Ib Received
Apr 30, 2022
New Representative At Ib Received
Apr 18, 2022
Refusal Processed By Ib
Mar 28, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 28, 2022
Teas Change Of Correspondence Received
Mar 28, 2022
Teas Change Of Domestic Representatives Address
Mar 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 28, 2022
Teas Change Of Owner Address Received
Mar 25, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 25, 2022
Refusal Processed By Mpu
Feb 19, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 18, 2022
Non-Final Action Written
Feb 11, 2022
Assigned To Examiner
Jan 25, 2022
Application Filing Receipt Mailed
Jan 21, 2022
New Application Office Supplied Data Entered
Jan 20, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24